Elyssa Rubin

711 total citations
15 papers, 566 citations indexed

About

Elyssa Rubin is a scholar working on Molecular Biology, Pathology and Forensic Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Elyssa Rubin has authored 15 papers receiving a total of 566 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 4 papers in Pathology and Forensic Medicine and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Elyssa Rubin's work include Sarcoma Diagnosis and Treatment (4 papers), Wnt/β-catenin signaling in development and cancer (4 papers) and Cancer-related gene regulation (4 papers). Elyssa Rubin is often cited by papers focused on Sarcoma Diagnosis and Treatment (4 papers), Wnt/β-catenin signaling in development and cancer (4 papers) and Cancer-related gene regulation (4 papers). Elyssa Rubin collaborates with scholars based in United States and United Kingdom. Elyssa Rubin's co-authors include Bang H. Hoang, Xiaolin Zi, Yi Guo, Jun Xie, Jonathan Kaye, Hui Shao, Lingyu Chen, Dwight H. Kono, Diane J. Nugent and Guy Young and has published in prestigious journals such as The Journal of Experimental Medicine, SHILAP Revista de lepidopterología and The Journal of Immunology.

In The Last Decade

Elyssa Rubin

15 papers receiving 562 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Elyssa Rubin United States	9	301	122	118	94	88	15	566
Borhane Guezguez Canada	13	259 0.9×	128 1.0×	118 1.0×	45 0.5×	60 0.7×	22	519
Z Zhu China	7	338 1.1×	49 0.4×	135 1.1×	92 1.0×	38 0.4×	8	432
Anna Zielinska‐Kwiatkowska United States	14	449 1.5×	49 0.4×	67 0.6×	83 0.9×	131 1.5×	17	594
Ana‐Violeta Fonseca Germany	7	213 0.7×	59 0.5×	191 1.6×	75 0.8×	36 0.4×	7	413
Samantha McGee United States	7	229 0.8×	141 1.2×	337 2.9×	147 1.6×	104 1.2×	8	628
Antonia Reale Italy	13	315 1.0×	94 0.8×	198 1.7×	112 1.2×	35 0.4×	32	560
Neal Fischbach United States	9	200 0.7×	38 0.3×	230 1.9×	88 0.9×	84 1.0×	21	499
Elizabeth M. Chislock United States	6	248 0.8×	75 0.6×	197 1.7×	39 0.4×	41 0.5×	6	469
Merete Thune Wiiger Norway	11	201 0.7×	80 0.7×	56 0.5×	96 1.0×	47 0.5×	20	515
M. Cengiz Yakıcıer Türkiye	14	375 1.2×	64 0.5×	164 1.4×	128 1.4×	45 0.5×	30	599

Countries citing papers authored by Elyssa Rubin

Since Specialization

Citations

This map shows the geographic impact of Elyssa Rubin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elyssa Rubin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elyssa Rubin more than expected).

Fields of papers citing papers by Elyssa Rubin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elyssa Rubin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elyssa Rubin. The network helps show where Elyssa Rubin may publish in the future.

Co-authorship network of co-authors of Elyssa Rubin

This figure shows the co-authorship network connecting the top 25 collaborators of Elyssa Rubin. A scholar is included among the top collaborators of Elyssa Rubin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elyssa Rubin. Elyssa Rubin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Tan, Serena Y., Mark G. Evans, Raya Saab, et al.. (2024). Aggressive Pediatric Primitive Round Cell Tumors with MN1::ZNF341 Fusion: A Mimic of Neuroblastoma. Pediatric Blood & Cancer. 72(1). e31425–e31425. 1 indexed citations

Reed, Damon R., Patrick J. Grohar, Elyssa Rubin, et al.. (2023). Children's Oncology Group's 2023 blueprint for research: Bone tumors. Pediatric Blood & Cancer. 70(S6). e30583–e30583. 4 indexed citations

Rubin, Elyssa, et al.. (2023). Bad to the Bone: Emerging Approaches to Aggressive Bone Sarcomas. American Society of Clinical Oncology Educational Book. 43(43). e390306–e390306. 10 indexed citations

Wyatt, Kirk D., Charles Phillips, Tamara P. Miller, et al.. (2022). Data standards in pediatric oncology: Past, present, and future. Pediatric Blood & Cancer. 70(2). e30128–e30128. 4 indexed citations

Kushner, Brian H., Shakeel Modak, Ellen M. Basu, et al.. (2021). Association of BRAF V600E mutations with vasoactive intestinal peptide syndrome in MYCN‐amplified neuroblastoma. Pediatric Blood & Cancer. 68(10). e29265–e29265. 8 indexed citations

Wiemels, Joseph L., Rong Wang, Qianxi Feng, et al.. (2020). Birth Characteristics and Risk of Early-Onset Synovial Sarcoma. Cancer Epidemiology Biomarkers & Prevention. 29(6). 1162–1167. 2 indexed citations

Glavis‐Bloom, Justin, et al.. (2019). Congenital neuroglial choristoma of the foot. SHILAP Revista de lepidopterología. 14(6). 718–722. 3 indexed citations

Buchbinder, David, Geetha Puthenveetil, Amit Soni, et al.. (2013). Successful autologous cord blood transplantation in a child with acquired severe aplastic anemia. Pediatric Transplantation. 17(3). E104–7. 6 indexed citations

McQueen, Peter, et al.. (2011). The Wnt signaling pathway: implications for therapy in osteosarcoma. Expert Review of Anticancer Therapy. 11(8). 1223–1232. 73 indexed citations

10.

Rubin, Elyssa, et al.. (2010). Wnt Inhibitory Factor 1 Decreases Tumorigenesis and Metastasis in Osteosarcoma. Molecular Cancer Therapeutics. 9(3). 731–741. 116 indexed citations

11.

Guo, Yi, Jun Xie, Elyssa Rubin, et al.. (2008). Frzb, a Secreted Wnt Antagonist, Decreases Growth and Invasiveness of Fibrosarcoma Cells Associated with Inhibition of Met Signaling. Cancer Research. 68(9). 3350–3360. 65 indexed citations

12.

Guo, Yi, Elyssa Rubin, Jun Xie, Xiaolin Zi, & Bang H. Hoang. (2008). Dominant Negative LRP5 Decreases Tumorigenicity and Metastasis of Osteosarcoma in an Animal Model. Clinical Orthopaedics and Related Research. 466(9). 2039–2045. 62 indexed citations

13.

Schneiderman, Jennifer, Elyssa Rubin, Diane J. Nugent, & Guy Young. (2007). Sequential therapy with activated prothrombin complex concentrates and recombinant FVIIa in patients with severe haemophilia and inhibitors: update of our previous experience. Haemophilia. 13(3). 244–248. 74 indexed citations

14.

Shao, Hui, et al.. (1997). A role for Ras signaling in coreceptor regulation during differentiation of a double-positive thymocyte cell line. The Journal of Immunology. 159(12). 5773–5776. 13 indexed citations

15.

Shao, Hui, Dwight H. Kono, Lingyu Chen, Elyssa Rubin, & Jonathan Kaye. (1997). Induction of the Early Growth Response (Egr) Family of Transcription Factors during Thymic Selection. The Journal of Experimental Medicine. 185(4). 731–744. 125 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact